Affymax, Inc. (AFFY)

USD 0.0

(-66.67%)

Revenue Summary of Affymax, Inc.

  • Affymax, Inc.'s latest annual revenue in 2013 was 1.36 Million USD , down -98.55% from previous year.
  • Affymax, Inc.'s latest quarterly revenue in 2014 Q2 was 42 Thousand USD , down 0.0% from previous quarter.
  • Affymax, Inc. reported a annual revenue of 94.37 Million USD in annual revenue 2012, up 97.76% from previous year.
  • Affymax, Inc. reported a annual revenue of 47.72 Million USD in annual revenue 2011, down -57.59% from previous year.
  • Affymax, Inc. reported a quarterly revenue of 42 Thousand USD for 2014 Q2, down 0.0% from previous quarter.
  • Affymax, Inc. reported a quarterly revenue of 525 Thousand USD for 2013 Q2, down -37.8% from previous quarter.

Annual Revenue Chart of Affymax, Inc. (2013 - 2001)

Historical Annual Revenue of Affymax, Inc. (2013 - 2001)

Year Revenue Revenue Growth
2013 1.36 Million USD -98.55%
2012 94.37 Million USD 97.76%
2011 47.72 Million USD -57.59%
2010 112.52 Million USD -2.07%
2009 114.89 Million USD 38.68%
2008 82.85 Million USD 86.87%
2007 44.33 Million USD 278.1%
2006 11.72 Million USD 15745.95%
2005 74 Thousand USD -50.99%
2004 151 Thousand USD -32.89%
2003 225 Thousand USD 118.45%
2002 103 Thousand USD 0.0%
2001 - USD 0.0%

Peer Revenue Comparison of Affymax, Inc.

Name Revenue Revenue Difference
Nuo Therapeutics, Inc. 608.52 Thousand USD -124.97%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -233.768%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Evofem Biosciences, Inc. 18.21 Million USD 92.485%
GB Sciences, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Zenith Capital Corp. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -1707.881%
Biomind Labs Inc. - USD -Infinity%
ContraFect Corporation - USD -Infinity%
CSL Limited 14.69 Billion USD 99.991%
CytoDyn Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 29.141%
ProtoKinetix, Incorporated - USD -Infinity%
Propanc Biopharma, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -478.712%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 98.887%
SQZ Biotechnologies Company 21.47 Million USD 93.626%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -1282.912%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 91.321%
Intellipharmaceutics International Inc. 65.72 Thousand USD -1982.826%
Mesoblast Limited 5.9 Million USD 76.804%
Marizyme, Inc. 645.81 Thousand USD -111.982%
Genus plc 668.8 Million USD 99.795%
Pharming Group N.V. 245.31 Million USD 99.442%
Nymox Pharmaceutical Corporation - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -1683.458%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -3364.244%
MultiCell Technologies, Inc. 49.32 USD -2775650.203%
ONE Bio Corp. 52.29 Million USD 97.382%
RVL Pharmaceuticals plc 49.72 Million USD 97.247%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 29.59 Million USD 95.375%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -145.468%
Oncotelic Therapeutics, Inc. 70 Thousand USD -1855.714%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -107.897%
Alpha Cognition Inc. - USD -Infinity%
Enzolytics Inc. 52.79 Thousand USD -2492.999%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.888%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -876.17%
Genscript Biotech Corporation 839.52 Million USD 99.837%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -7669.139%
Institute of Biomedical Research Corp. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Accustem Sciences Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -37.212%
EV Biologics, Inc. 48.9 Thousand USD -2699.591%
Q BioMed Inc. 284.35 Thousand USD -381.446%
Capstone Therapeutics Corp. 48.35 Million USD 97.169%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.057%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 91.795%
Curative Biotechnology, Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -136937.037%
Resverlogix Corp. - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -121.742%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -478.712%
Itoco Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 82.424%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
Bioxytran, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -188.983%
SYBLEU INC 11.69 Thousand USD -11604.856%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -10430.769%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -3362.842%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 58.889%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 79.46%
IntelGenx Technologies Corp. 1.03 Million USD -31.761%
Gelesis Holdings, Inc. 25.76 Million USD 94.687%
CSL Limited 14.8 Billion USD 99.991%
Cellectis S.A. 755 Thousand USD -81.325%